Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Faster, Cleaner, Better.

Alseres Pharmaceuticals Inc (ALSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2013	12-2012	09-2012	06-2012	03-2012
Assets
Current Assets
Cash & Cash Equivalents	93	17	25	64	122
Marketable Securities	167	881	880	20	33
TOTAL	$291	$900	$953	$128	$207

Non-Current Assets
PPE Net	N/A	1	1	2	2
Other Non-Current Assets	64	65	65	0	0
TOTAL	$64	$66	$67	$2	$2

Total Assets	$354	$966	$1,020	$130	$209

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,031	2,603	2,292	2,297	2,209
Other current liabilities	N/A	60	75	N/A	N/A
TOTAL	$9,545	$10,067	$15,485	$31,005	$30,777

Non-Current Liabilities
Deferred Revenues	74	74	74	N/A	250
Other Non-Current Liabilities	16,408	16,403	16,398	359	354
TOTAL	$17,607	$17,620	$17,633	$359	$354

Total Liabilities	$27,152	$27,687	$33,118	$31,364	$31,130

Shareholders' Equity
Shares Outstanding, K	6	6	6	6	6
Common Shares	306	306	306	306	306
Retained earnings	-198,991	-198,694	-198,234	-197,662	-197,367
Other shareholders' equity	-83	-309	-325	-39	-26
TOTAL	$-26,798	$-26,721	$-32,098	$-31,234	$-30,921

Total Liabilities And Equity	$354	$966	$1,020	$130	$209